[Study by the Working Group in Gynecologic Oncology for therapeutic optimization in advanced FIGO IIb-IV ovarian carcinoma: cisplatin-paclitaxel vs. carboplatin-paclitaxel. AGO Protocol Ovar-3].
作者信息
Mettler L
机构信息
Korrespondenzanschrif, Prof. Dr. med Liselotte Mettler, Univ. Frauenklinik Kiel, Bundesre-publik Deutschland.
出版信息
Zentralbl Gynakol. 1996;118(6):379-4.
PMID:8768017
Abstract
摘要
Zotero 插件